0.230
0.00 (0.00%)
| Previous Close | 0.230 |
| Open | 0.230 |
| Market Cap | 34,272,300 |
| Price / Earnings (TTM) | 23.00 |
| Price / Sales | 4.81 |
| Price / Book | 3.05 |
| 52 Weeks Range | |
| TTM Dividend Yield | 34.78% |
| Profit Margin | 37.97% |
| Operating Margin (TTM) | 45.96% |
| Diluted EPS (TTM) | 0.010 |
| Quarterly Revenue Growth (YOY) | 39.70% |
| Quarterly Earnings Growth (YOY) | 565.00% |
| Total Debt/Equity (MRQ) | 0.69% |
| Current Ratio (MRQ) | 4.55 |
| Operating Cash Flow (TTM) | 5.50 M |
| Levered Free Cash Flow (TTM) | 6.62 M |
| Return on Assets (TTM) | 19.34% |
| Return on Equity (TTM) | 30.89% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Engineering & Construction (MY) | Bullish | Mixed |
| Engineering & Construction (Global) | Bullish | Bullish | |
| Stock | NPS | - | - |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | NA |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | 1.33 |
|
Nova Pharma Solutions Bhd is principally engaged in the business of providing technical documentation, validation, and project execution in the pharmaceutical and biological industries. The group focuses on the design and building phase of pharmaceutical and biotechnology plants, providing engineering solutions ranging from pre-design (feasibility study and site selection), design (conceptual design, basic design, and detailed design), post-design (tendering, procurement and site supervision) to other supporting activities (GMP documents review and gap analysis and assessment). Its reportable segments include Post Design fee, which derives maximum revenue, Design fee, EPCC, and Other support fees. Geographically, the group generates a majority of its revenue from Malaysia. |
|
| Sector | Industrials |
| Industry | Engineering & Construction |
| Investment Style | Small Growth |
| % Held by Insiders | 73.44% |
No data within this time range.
No data within this time range.
| TTM Dividend Yield | 34.78% |
| 3Y Average Dividend Yield | 1.96% |
| Expected Next Dividend Payment | Dec 2026 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 28 Nov 2025 | 21 Nov 2025 | 26 Dec 2025 | 0.08 Cash |
| 11 Dec 2024 | 25 Nov 2024 | 27 Dec 2024 | 0.006 Cash |
| 29 Aug 2023 | 21 Aug 2023 | 15 Sep 2023 | 0.005 Cash |
| 01 Sep 2022 | 23 Aug 2022 | 15 Sep 2022 | 0.0025 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2025 | 0.080 | 1 | 34.78 |
| 2024 | 0.006 | 1 | 2.61 |
| 2023 | 0.005 | 1 | 2.17 |
| 2022 | 0.003 | 1 | 1.09 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |